SCHRODER VENTURES
Schroders is a global asset management company with £103.1 billion (EUR 111.3 billion / $147.7 billion) under management as at 31 March 2009. their clients include corporations, insurance companies, local and public authorities, charities, pension funds, high net worth individuals and retail investors.
SCHRODER VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
1804-01-01
Status:
Active
Contact:
+44 (0)20 7658 6000
Email Addresses:
[email protected]
Current Employees Featured
Olaf Siedler
Olaf Siedler Portfolio Manager @ Schroder Ventures Portfolio Manager
Matthew Rho
Matthew Rho Vice President @ Schroder Ventures Vice President
Kathleen Jordan Stowe
Kathleen Jordan Stowe Principal @ Schroder Ventures Principal
Founder
Nicholas Ferguson
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2001-07-04 | Market Place Media | Market Place Media acquired by Schroder Ventures | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-02-06 | Antler | Schroder Ventures investment in Venture Round - Antler | 25 M USD |
2018-07-04 | Albert Technologies | Schroder Ventures investment in Post-IPO Equity - Albert Technologies | 18 M USD |
2008-08-28 | AEA Technology | Schroder Ventures investment in Series A - AEA Technology | 6.5 M USD |
2006-02-16 | Insulet Corporation | Schroder Ventures investment in Series E - Insulet Corporation | 50 M USD |
2005-10-19 | Lorantis | Schroder Ventures investment in Series C - Lorantis | 25 M GBP |
2005-07-15 | Quick Study Radiology | Schroder Ventures investment in Series C - Quick Study Radiology | 1.2 M USD |
2005-01-27 | Medifacts International | Schroder Ventures investment in Series A - Medifacts International | 16 M USD |
2004-10-14 | Quick Study Radiology | Schroder Ventures investment in Series C - Quick Study Radiology | 902 K USD |
2004-09-29 | Solexa | Schroder Ventures investment in Series B - Solexa | 14.4 M USD |
2004-08-05 | Avera Pharmaceutical | Schroder Ventures investment in Series C - Avera Pharmaceutical | 48 M USD |